Characterisation of the Novel HLA ‐C*16:01:01: 42Q Allele by Sequencing‐Based Typing
HLA · 2025
DOI: 10.1111/tan.70229 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2025. Verfasst von Thibault Pajot und 3 weiteren Autor:innen. Beteiligte Einrichtung: CHU de Lille, Institut d'Immunologie-HLA, Lille, France. Hauptthemen laut MEDLINE: Alleles, Exons, HLA-C Antigens, Polymorphism, Single Nucleotide. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
HLA‐C*16:01:01:42Q differs from HLA‐C*16:01:01:01 by one nucleotide substitution in the splicing site between intron 2 and exon 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CHU de Lille, Institut d'Immunologie-HLA, Lille, France.
- Université de Lille, Inserm U1286 INFINITE, Lille, France.
ORCID-Profile: Thibault Pajot
Zitieren
APA
Pajot, T., Elsermans, V., Top, I., & Labalette, M. (2025). Characterisation of the Novel HLA ‐C*16:01:01: 42Q Allele by Sequencing‐Based Typing. HLA. https://doi.org/10.1111/tan.70229
Vancouver
Pajot T, Elsermans V, Top I, Labalette M. Characterisation of the Novel HLA ‐C*16:01:01: 42Q Allele by Sequencing‐Based Typing. HLA. 2025. doi:10.1111/tan.70229
BibTeX
@article{Pajot2025,
author = {Pajot, Thibault and Elsermans, Vincent and Top, Isabelle and Labalette, Myriam},
title = {Characterisation of the Novel HLA ‐C*16:01:01: 42Q Allele by Sequencing‐Based Typing},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70229}
}
EUVIMED